Trivium Point Advisory LLC Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Trivium Point Advisory LLC bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 58,905 shares of the company’s stock, valued at approximately $4,831,000.

Several other large investors have also recently added to or reduced their stakes in GEHC. E Fund Management Hong Kong Co. Ltd. raised its holdings in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the period. Godsey & Gibb Inc. purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Optima Capital LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $27,000. Maseco LLP acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $29,000. Finally, Oakworth Capital Inc. boosted its stake in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

GEHC has been the topic of several analyst reports. BTIG Research reaffirmed a “buy” rating and set a $91.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, March 19th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Evercore increased their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Morgan Stanley lifted their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Finally, Citigroup reduced their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $90.69.

GE HealthCare Technologies Stock Down 0.4%

NASDAQ:GEHC opened at $73.20 on Friday. The stock has a 50-day simple moving average of $75.57 and a 200 day simple moving average of $77.92. GE HealthCare Technologies Inc. has a one year low of $59.95 and a one year high of $89.77. The company has a market capitalization of $33.40 billion, a price-to-earnings ratio of 16.05, a price-to-earnings-growth ratio of 1.62 and a beta of 1.17. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.